Phase 2/3 clinical trials of the intranasal vaccine are likely to begin in the next two weeks as an application has been put to seek permission of the Ethics Committee.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.